miami semaglutide class action 2 Florida sellers of Ozempic knockoffs settle with Novo Nordisk Ozempic® Lawsuit | July 2026

A new study led by researchers at the University of Oxford, which reviewed 37 existing weight loss medication studies involving over 9,000 participants, has found that patients who stopped taking GLP-1 weight-loss medications regained weight four times as fast as those who used alternative behavioral programs, like diets and physical activity

Then, across 50+ clinical studies in major neurocognitive disorders including Alzheimers dementia, Parkinsons disease & Lewy-body dementia, and other cognitive deficits, despite some inconsistencies and translational gaps, they found that the overall evidence seems encouraging and possibly even suggestive of GLP-1RAs disease-modifying properties in dementia

Were very careful with that

Semaglutide markedly decreased body weight (Fig